ES2051690T3 - Un complejo y su procedimiento de preparacion. - Google Patents
Un complejo y su procedimiento de preparacion.Info
- Publication number
- ES2051690T3 ES2051690T3 ES86307849T ES86307849T ES2051690T3 ES 2051690 T3 ES2051690 T3 ES 2051690T3 ES 86307849 T ES86307849 T ES 86307849T ES 86307849 T ES86307849 T ES 86307849T ES 2051690 T3 ES2051690 T3 ES 2051690T3
- Authority
- ES
- Spain
- Prior art keywords
- complex
- preparation procedure
- molecula
- immunogen
- pharmacy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000000975 bioactive effect Effects 0.000 abstract 2
- 239000005556 hormone Substances 0.000 abstract 2
- 229940088597 hormone Drugs 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 abstract 1
- 239000002131 composite material Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000004044 response Effects 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Vending Machines For Individual Products (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A UN COMPLEJO DE UN FARMACO, HORMONA, PEPTIDO BIOACTIVO, O INMUNOGENO CON EL SOPORTE DE LA MOLECULA DE VITAMINA B12 Y UN METODO PARA SUMINISTRAR DICHO COMPLEJO AL INTESTINO DE UN VERTEBRADO HUESPED CON EL FIN DE SUMINISTRAR EL COMPLEJO A LA CIRCULACION DEL HUESPED Y ELICITAR POR TANTO UNA RESPUESTA FARMACOLOGICA AL FARMACO, HORMONA O MOLECULA BIOACTIVA O ELICITAR UNA RESPUESTA INMUNOLOGICA SISTEMICA AL INMUNOGENO. LA INVENCION TAMBIEN PROPORCIONA UN METODO PARA LA PRODUCCION DEL COMPLEJO. ADEMAS LA INVENCION PROPORCIONA MEDICAMENTOS QUE CONTIENEN EL COMPLEJO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPH283885 | 1985-10-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2051690T3 true ES2051690T3 (es) | 1994-07-01 |
Family
ID=3771313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES86307849T Expired - Lifetime ES2051690T3 (es) | 1985-10-10 | 1986-10-10 | Un complejo y su procedimiento de preparacion. |
Country Status (16)
Country | Link |
---|---|
US (2) | US5428023A (es) |
EP (1) | EP0220030B1 (es) |
JP (1) | JPH08779B2 (es) |
KR (1) | KR940003057B1 (es) |
CN (1) | CN1045391C (es) |
AT (1) | ATE64534T1 (es) |
CA (1) | CA1330791C (es) |
DK (1) | DK167099B1 (es) |
ES (1) | ES2051690T3 (es) |
GR (1) | GR3002160T3 (es) |
HK (1) | HK69094A (es) |
IL (1) | IL80264A (es) |
IN (1) | IN165029B (es) |
NZ (1) | NZ217821A (es) |
WO (1) | WO1987002251A1 (es) |
ZA (1) | ZA867703B (es) |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643889A (en) * | 1984-07-11 | 1997-07-01 | Temple University-Of The Commonwealth System Of Pennsylvania | Cholesterol conjugates of 2'5'-oligoadenylate derivatives and antiviral uses thereof |
US5550111A (en) * | 1984-07-11 | 1996-08-27 | Temple University-Of The Commonwealth System Of Higher Education | Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof |
NZ217821A (en) * | 1985-10-10 | 1989-07-27 | Biotech Australia Pty Ltd | Oral delivery system; complex of active agent and vitamin b12 or analogue thereof |
US4842868A (en) * | 1986-09-26 | 1989-06-27 | Helwing Robert F | Covalently bonded active agents with carbonium ion base groups |
US5807832A (en) * | 1987-06-09 | 1998-09-15 | Biotech Australia Pty Limited | Oral delivery of biologically active substances bound to vitamin B12 |
US4997815A (en) * | 1988-11-01 | 1991-03-05 | Children's Hospital Medical Center Of Northern California | Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin |
US5108921A (en) * | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
US5688488A (en) * | 1989-04-03 | 1997-11-18 | Purdue Research Foundation | Composition and method for tumor imaging |
WO1990012095A1 (en) * | 1989-04-03 | 1990-10-18 | Purdue Research Foundation | Method for enhancing transmembrane transport of exogenous molecules |
FR2649321A1 (fr) * | 1989-07-07 | 1991-01-11 | Inst Nat Sante Rech Med | Compositions a base de derives nucleotidiques, leurs procedes de preparation, et leurs utilisations notamment en tant que compositions pharmaceutiques |
GR900100249A (el) * | 1990-03-28 | 1992-06-30 | Purdue Research Foundation | Μεθοδος δια την ηυξημενην δια των μεμβρανων μεταφοραν εξωγενων μοριων. |
ATE156705T1 (de) * | 1991-04-02 | 1997-08-15 | Biotech Australia Pty Ltd | Systeme zur oralen freisetzung von mikropartikeln |
WO1994028015A1 (en) * | 1993-05-20 | 1994-12-08 | Biotech Australia Pty. Limited | Lhrh antagonists |
US5548064A (en) * | 1993-05-24 | 1996-08-20 | Biotech Australia Pty Limited | Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions |
US5449720A (en) * | 1993-05-24 | 1995-09-12 | Biotech Australia Pty Limited | Amplification of the VB12 uptake system using polymers |
US5840880A (en) * | 1994-04-08 | 1998-11-24 | Receptagen Corporation | Receptor modulating agents |
US5739287A (en) * | 1994-04-08 | 1998-04-14 | University Of Washington | Biotinylated cobalamins |
US5869465A (en) * | 1994-04-08 | 1999-02-09 | Receptagen Corporation | Methods of receptor modulation and uses therefor |
ATE225799T1 (de) * | 1994-04-08 | 2002-10-15 | Receptagen Corp | Rezeptor modulierendes mitteln und entsprechendes verfahren |
US5574018A (en) * | 1994-07-29 | 1996-11-12 | Amgen Inc. | Conjugates of vitamin B12 and proteins |
WO1996006632A1 (en) * | 1994-09-01 | 1996-03-07 | Allied Medical Research Associates | Compositions and methods for delivery of polypeptides |
WO1997014711A1 (en) * | 1995-10-19 | 1997-04-24 | Receptagen Corporation | Vitamin b12 receptor modulating agents and methods related thereto |
US5739313A (en) * | 1995-11-13 | 1998-04-14 | Regents Of The University Of Minnesota | Radionuclide labeling of vitamin B12 and coenzymes thereof |
JP2001501596A (ja) | 1996-08-27 | 2001-02-06 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション | バイオコンジュゲートおよび生物学的活性剤の送達 |
US6054133A (en) * | 1997-07-10 | 2000-04-25 | The Regents Of The University Of California | Anti-microbial targeting for intracellular pathogens |
AU4328399A (en) * | 1998-06-15 | 2000-01-05 | Alza Corporation | Nucleic acid-cobalamin complexes and their use in gene therapy |
FR2787029A1 (fr) * | 1998-12-09 | 2000-06-16 | Biovector Therapeutics | Utilisation dans une composition pharmaceutique pour l'administration par voie nasale de vitamine b12 pour la delivrance d'agents actifs au systeme nerveux central |
US20010008627A1 (en) | 1999-01-22 | 2001-07-19 | Soll David R. | Hiv-encoded chemoattractant |
US6806363B1 (en) | 1999-04-16 | 2004-10-19 | Mayo Foundation For Medical Education & Research | Cobalamin conjugates useful as antitumor agents |
DE19930729A1 (de) * | 1999-07-05 | 2001-01-11 | Achim Goepferich | Blockcopolymere zur Herstellung biomimetischer Oberflächen |
CA2387757A1 (en) * | 1999-10-15 | 2001-04-26 | Henricus P. C. Hogenkamp | Cobalamin conjugates useful as imaging agents and as antitumor agents |
EP1239887A1 (en) | 1999-10-15 | 2002-09-18 | Mayo Foundation For Medical Education And Research | Cobalamin conjugates useful as imaging and therapeutic agents |
US7591995B2 (en) | 1999-10-15 | 2009-09-22 | Mayo Foundation For Medical Education And Research | Cobalamin conjugates useful as imaging and therapeutic agents |
NZ521898A (en) | 2000-03-31 | 2004-11-26 | Purdue Research Foundation | Use of a ligand-immunogen conjugate such as folate-FITC for enhancing an endogenous immune response |
EP1754712A3 (en) * | 2000-10-25 | 2009-01-14 | Mayo Foundation For Medical Education And Research | Transcobalamin binding conjugates useful for treating abnormal cellular proliferation |
WO2002055530A2 (en) * | 2000-10-25 | 2002-07-18 | Mayo Foundation | Transcobalamin binding conjugates useful for treating abnormal cellular proliferation |
WO2002067995A1 (en) * | 2001-02-26 | 2002-09-06 | Council Of Scientific And Industrial Research | Carrier systems comprising vitamin b12 - biodegradable micro particulate conju gates for peroral delivery of drugs, peptides/proteins and vaccines |
KR20040015234A (ko) | 2001-05-02 | 2004-02-18 | 펄듀 리서치 파운데이션 | 대식세포 매개된 질환의 치료와 진단 |
US6752986B2 (en) | 2001-05-24 | 2004-06-22 | The Cleveland Clinic Foundation | Composition and methods for affecting metallocorrinoid uptake |
US20030018009A1 (en) * | 2001-06-20 | 2003-01-23 | Collins Douglas A. | Adenosyl-cobalamin fortified compositions |
US20060074034A1 (en) * | 2001-09-17 | 2006-04-06 | Collins Douglas A | Cobalamin mediated delivery of nucleic acids, analogs and derivatives thereof |
WO2003028634A2 (en) * | 2001-09-28 | 2003-04-10 | Purdue Research Foundation | Method of treatment using ligand-immunogen conjugates |
EP1435973A4 (en) * | 2001-09-28 | 2007-05-02 | Mayo Foundation | SIMULTANEOUS ADMINISTRATION OF A TRANSPORT PROTEIN WITH CONJUGATED COBALAMINE FOR THE DISTRIBUTION OF MEDICINAL PRODUCTS |
US7255874B1 (en) | 2001-12-21 | 2007-08-14 | Closure Medical Corporation | Biocompatible polymers and adhesives: compositions, methods of making and uses related thereto |
US8043603B2 (en) | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
US8043602B2 (en) | 2002-02-07 | 2011-10-25 | Endocyte, Inc. | Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology |
FR2839407B1 (fr) * | 2002-05-02 | 2004-12-17 | Canon Kk | Procede et dispositif d'ajustement de la taille maximale des sequences d'information transmises dans un reseau de telecommunications |
CN101648028B (zh) | 2002-05-06 | 2012-11-21 | 恩多塞特公司 | 维生素-定向的显象剂 |
KR100440725B1 (ko) * | 2002-06-20 | 2004-07-15 | 주식회사 그린진 바이오텍 | 비생물성 스트레스에 대한 단자엽 식물의 내성을증가시키는 방법 |
KR20040080778A (ko) | 2003-03-13 | 2004-09-20 | 삼성전자주식회사 | 4색 구동 액정 표시 장치 및 이에 사용하는 표시판 |
US7232805B2 (en) * | 2003-09-10 | 2007-06-19 | Inflabloc Pharmaceuticals, Inc. | Cobalamin conjugates for anti-tumor therapy |
EP1773354A4 (en) * | 2004-08-02 | 2010-05-05 | Bebaas Inc | COMPOSITIONS OF VITAMIN B12 |
BRPI0610419A2 (pt) * | 2005-05-17 | 2012-10-23 | Cargill Inc | lecitina granular, lisolecitina, processo para produzir lecitina granular, composição granular, processo para produzir uma composição de lecitina granular, produto, e, processos para produzir lisolecitina granular e para produzir uma composição de lisolecitina granular |
US20070009434A1 (en) | 2005-07-05 | 2007-01-11 | Low Philip S | Imaging and therapeutic method using monocytes |
EP1933851A4 (en) * | 2005-09-07 | 2008-09-24 | Bebaas Inc | COMPOSITIONS OF VITAMIN B12 |
US20070178141A1 (en) * | 2005-09-07 | 2007-08-02 | Bebaas, Inc. | Vitamin B12 compositions |
US20130131007A1 (en) | 2005-09-07 | 2013-05-23 | Bebaas, Inc. | Vitamin b12 compositions |
WO2007038346A2 (en) | 2005-09-23 | 2007-04-05 | Purdue Research Foundation | Multiphoton in vivo flow cytometry method and device |
US20130084329A1 (en) | 2005-12-09 | 2013-04-04 | Hanall Biopharma Co., Ltd. | Compositions for external application, containing adenosylcobalamin for improvement of skin diseases |
KR100658436B1 (ko) * | 2005-12-09 | 2006-12-27 | 한국화학연구원 | 아데노실코발라민 함유 피부질환 치료용 외용제 조성물 |
WO2007092299A2 (en) | 2006-02-03 | 2007-08-16 | Purdue Research Foundation | Targeted conjugates and radiation |
US8685752B2 (en) | 2006-11-03 | 2014-04-01 | Purdue Research Foundation | Ex vivo flow cytometry method and device |
US8586595B2 (en) | 2007-02-07 | 2013-11-19 | Purdue Research Foundation | Positron emission tomography imaging method |
US8883723B2 (en) * | 2007-03-05 | 2014-11-11 | Syracuse University | Conjugate of insulin and vitamin B12 for oral delivery |
US20110092416A1 (en) * | 2007-03-05 | 2011-04-21 | Robert Patrick Doyle | Vitamine B12 - Peptide Conjugates for Oral Delivery |
US7851342B2 (en) * | 2007-03-30 | 2010-12-14 | Intel Corporation | In-situ formation of conductive filling material in through-silicon via |
WO2008148001A2 (en) | 2007-05-25 | 2008-12-04 | Purdue Research Foundation | Method of imaging localized infections |
CA2695366C (en) * | 2007-08-03 | 2016-10-04 | Shaklee Corporation | Nutritional supplement system |
US20100330161A1 (en) * | 2009-06-29 | 2010-12-30 | Syracuse University Technology Transfer And Industrial Development Office | Oral delivery of tetanus toxoid |
WO2011130716A2 (en) | 2010-04-16 | 2011-10-20 | Access Pharmaceuticals, Inc. | A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers |
US8614184B2 (en) | 2010-09-22 | 2013-12-24 | Ronald P. Santasiero | HCG formulations for achieving weight loss |
KR20140026396A (ko) | 2011-03-08 | 2014-03-05 | 어섹스 팔마큐티칼스 인코포레이티드 | 생물학적 막을 가로질러 활성물질의 전달을 위한 표적화된 나노담체 시스템 |
US9120858B2 (en) | 2011-07-22 | 2015-09-01 | The Research Foundation Of State University Of New York | Antibodies to the B12-transcobalamin receptor |
AU2013263349B2 (en) | 2012-05-17 | 2016-09-08 | Extend Biosciences, Inc | Carriers for improved drug delivery |
WO2015126841A1 (en) | 2014-02-18 | 2015-08-27 | Plasmatech Biopharmaceuticals, Inc. | Nutritional and therapeutic mucoadhesive formulations |
WO2016065052A1 (en) | 2014-10-22 | 2016-04-28 | Extend Biosciences, Inc. | Insulin vitamin d conjugates |
CA2964463C (en) | 2014-10-22 | 2024-02-13 | Extend Biosciences, Inc. | Therapeutic vitamin d conjugates |
US9789197B2 (en) | 2014-10-22 | 2017-10-17 | Extend Biosciences, Inc. | RNAi vitamin D conjugates |
US10420850B2 (en) | 2015-08-14 | 2019-09-24 | Endocyte, Inc. | Method of imaging with a chelating agent |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2372066A (en) * | 1940-12-23 | 1945-03-20 | Parke Davis & Co | Biological product and process of obtaining same |
US3042588A (en) * | 1957-04-04 | 1962-07-03 | Distillers Co Yeast Ltd | Process for producing cobalaminpeptide complexes |
GB963373A (en) * | 1961-12-11 | 1964-07-08 | Glaxo Group Ltd | Improvements in or relating to substituted cobamides |
GB1152461A (en) * | 1965-06-16 | 1969-05-21 | Ivan Rolovich | New Derivatives of Cobalamins |
FR5372M (es) * | 1966-02-10 | 1967-10-16 | ||
LU64101A1 (es) * | 1970-10-28 | 1973-05-03 | ||
IT1044233B (it) * | 1973-04-04 | 1980-03-20 | Zambelletti L S P A | Derivati della vitamina bi2 ad azione vitaminica di lunga durata |
JPS5247012B2 (es) * | 1974-11-16 | 1977-11-29 | ||
US3981863A (en) * | 1975-02-25 | 1976-09-21 | Micromedic Diagonistics, Inc. | Cyanocobalamin derivatives |
US4133951A (en) * | 1975-05-08 | 1979-01-09 | The Radiochemical Centre Limited | Vitamin B-12 cobalt-57 and process |
DE2546474A1 (de) * | 1975-10-17 | 1977-04-21 | Murray M D Israel | Injizierbares pharmazeutisches thyroxinpraeparat und verfahren zu dessen herstellung |
FR2373285A1 (fr) * | 1976-11-25 | 1978-07-07 | Roussel Uclaf | Nouveaux derives du coenzyme b 12, procede de preparation et application a titre de medicaments de ces nouveaux produits |
DE2718700A1 (de) * | 1977-04-27 | 1978-11-02 | Hans A Dipl Chem Dr Thoma | Verfahren zur gesamtbestimmung von hormonen und pharmaka |
US4209614A (en) * | 1978-05-30 | 1980-06-24 | E. R. Squibb & Sons, Inc. | Vitamin B12 derivative suitable for radiolabeling |
US4377570A (en) * | 1979-01-29 | 1983-03-22 | Merck & Co., Inc. | Immunologically active dipeptidyl saccharides and methods of preparation |
US4360358A (en) * | 1980-03-07 | 1982-11-23 | Yash Sharma | Immunoassay with solid phase having coating containing blood platelet substitute |
CA1165238A (en) * | 1980-03-12 | 1984-04-10 | Demetrios P. Papahadjopoulos | Activated liposomes and method |
DE3176524D1 (en) * | 1981-06-22 | 1987-12-17 | Battelle Memorial Institute | A method for determining bioactive substances |
DE3262956D1 (en) * | 1981-06-22 | 1985-05-15 | Technicon Instr | Labelled vitamin b12 derivatives, their preparation and use |
US4454125A (en) * | 1982-04-22 | 1984-06-12 | Demopoulos Harry B | Dry powder formulations having improved flow and compressibility characteristics, and method for the preparation thereof |
US4452775A (en) * | 1982-12-03 | 1984-06-05 | Syntex (U.S.A.) Inc. | Cholesterol matrix delivery system for sustained release of macromolecules |
US4603044A (en) * | 1983-01-06 | 1986-07-29 | Technology Unlimited, Inc. | Hepatocyte Directed Vesicle delivery system |
US4746508A (en) * | 1983-06-06 | 1988-05-24 | Beth Israel Hospital Assn. | Drug administration |
NZ217821A (en) * | 1985-10-10 | 1989-07-27 | Biotech Australia Pty Ltd | Oral delivery system; complex of active agent and vitamin b12 or analogue thereof |
US4751285A (en) * | 1986-10-09 | 1988-06-14 | Toohey John I | Derivative of cobalamin containing persulfide sulfur and glutathione |
US5075109A (en) * | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
IL84167A (en) * | 1986-10-24 | 1991-04-15 | Southern Res Inst | Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation |
-
1986
- 1986-10-07 NZ NZ217821A patent/NZ217821A/xx unknown
- 1986-10-09 IN IN738/CAL/86A patent/IN165029B/en unknown
- 1986-10-09 ZA ZA867703A patent/ZA867703B/xx unknown
- 1986-10-09 CA CA000520162A patent/CA1330791C/en not_active Expired - Fee Related
- 1986-10-09 IL IL80264A patent/IL80264A/xx not_active IP Right Cessation
- 1986-10-10 CN CN86107590A patent/CN1045391C/zh not_active Expired - Lifetime
- 1986-10-10 ES ES86307849T patent/ES2051690T3/es not_active Expired - Lifetime
- 1986-10-10 KR KR1019870700489A patent/KR940003057B1/ko not_active IP Right Cessation
- 1986-10-10 US US08/061,343 patent/US5428023A/en not_active Expired - Lifetime
- 1986-10-10 AT AT86307849T patent/ATE64534T1/de not_active IP Right Cessation
- 1986-10-10 JP JP61505525A patent/JPH08779B2/ja not_active Expired - Fee Related
- 1986-10-10 EP EP86307849A patent/EP0220030B1/en not_active Expired - Lifetime
- 1986-10-10 WO PCT/AU1986/000299 patent/WO1987002251A1/en unknown
-
1987
- 1987-06-09 DK DK292587A patent/DK167099B1/da not_active IP Right Cessation
-
1991
- 1991-06-20 GR GR91400298T patent/GR3002160T3/el unknown
-
1994
- 1994-07-14 HK HK69094A patent/HK69094A/xx not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/479,635 patent/US5589463A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK292587D0 (da) | 1987-06-09 |
WO1987002251A1 (en) | 1987-04-23 |
ZA867703B (en) | 1987-06-24 |
IL80264A (en) | 1991-11-21 |
ATE64534T1 (de) | 1991-07-15 |
DK167099B1 (da) | 1993-08-30 |
EP0220030A2 (en) | 1987-04-29 |
IN165029B (es) | 1989-08-05 |
HK69094A (en) | 1994-07-22 |
KR870700361A (ko) | 1987-12-28 |
JPS63501015A (ja) | 1988-04-14 |
DK292587A (da) | 1987-06-09 |
JPH08779B2 (ja) | 1996-01-10 |
CN1045391C (zh) | 1999-10-06 |
KR940003057B1 (ko) | 1994-04-13 |
EP0220030A3 (en) | 1987-09-30 |
US5589463A (en) | 1996-12-31 |
CN86107590A (zh) | 1987-05-20 |
CA1330791C (en) | 1994-07-19 |
IL80264A0 (en) | 1987-01-30 |
NZ217821A (en) | 1989-07-27 |
EP0220030B1 (en) | 1991-06-19 |
US5428023A (en) | 1995-06-27 |
GR3002160T3 (en) | 1992-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2051690T3 (es) | Un complejo y su procedimiento de preparacion. | |
MX9206306A (es) | Peptidos, procedimiento para su produccion y composicion farmaceutica que los contiene. | |
ATE189400T1 (de) | Knochenwachstumsfördernde zusammensetzung | |
ES2019570B3 (es) | Dispositivo para el tratamiento termico del cuello de los preformados. | |
ATE94390T1 (de) | Orale darreichungsformen mit verzoegerter abgabe. | |
ES2023976B3 (es) | Procedimiento para el enriquecimiento de helio. | |
ES2143132T3 (es) | Monohidratos de derivado de acido aminobenceno-sulfonico y su metodo de preparacion. | |
AR025052A1 (es) | Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos. | |
ES8307494A1 (es) | "un procedimiento para preparar una composicion farmaceutica que proporciona un efecto anti-inflamatorio y analgesico junto con un dano gastrico minimizado". | |
ES2019595B3 (es) | Empleo de glicofurol para licuacion de preparaciones medicas, para el llenado en capsulas de gelatina blanda | |
EP0078215A3 (en) | Solid galenic form for oral administration and process for its preparation | |
AR030662A1 (es) | Beta-tio-alfa-aminoacidos, procedimiento para su fabricacion, medicamentos que contienen estos compuestos y el uso de los tioaminoacidos para la preparacion de medicamentos | |
AR011457A1 (es) | Sales de bismuto de antibioticos del grupo de la moenomicina, procedimiento para su preparacion, su utilizacion y medicamentos que contienen tales sales | |
AR003434A1 (es) | Compuesto de tiludronato, composiciones farmaceuticas que los contienen y proceso para producir dicho compuesto y procedimiento para producir lascomposiciones farmaceuticas. | |
NO863082D0 (no) | Preparat for intramuskulaer injeksjon av legemidler, vitaminer eller vaksiner. | |
ES2045157T3 (es) | Composiciones cosmeticas de aplicacion topica y su procedimiento de preparacion. | |
ES2061718T3 (es) | Utilizacion de antigestagenos para la preparacion de medicamentos. | |
AR247723A1 (es) | Nuevo procedimiento para preparar acido 4-amino-5-hexenoico y nuevo compuesto intermedio producido por este procedimento | |
ES2036523T3 (es) | 4-aminoarildihidropiridinlactonas, procedimiento para su obtencion y su empleo en medicamentos. | |
SV1992000012A (es) | Proceso para fabricar derivados de aminoacidos. ref. ran 4070/81 | |
ES548888A0 (es) | Tunel para el tratamiento termico de frascos de vidrio | |
ES240074Y (es) | Tarjeta para el control de horarios en la administracion de medicamentos. | |
IT8636067V0 (it) | Cono e simili per gelato da passeggio,con decorazione a bandiera e struttura anti-sgocciolamento | |
ES205570Y (es) | Metodo para encapsular hermeticamente el cuello de bote- llas. | |
SV1987000046A (es) | Metodo para fabricar derivados de piramida, ref. ran 4430/20. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 220030 Country of ref document: ES |